Literature DB >> 22789725

Molecular correlates of the spread of KPC-producing Enterobacteriaceae in Colombia.

María F Mojica, Adriana Correa, Deninson A Vargas, Juan J Maya, María C Montealegre, Laura J Rojas, Sory J Ruiz, John P Quinn, María V Villegas.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22789725     DOI： 10.1016/j.ijantimicag.2012.05.006

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  14 in total

1.  Emergence of Klebsiella pneumoniae Coharboring KPC and VIM Carbapenemases in Colombia.

Authors:  L J Rojas; M F Mojica; V M Blanco; A Correa; M C Montealegre; E De La Cadena; J J Maya; R D Camargo; J P Quinn; M V Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

Review 2.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

Review 3.  The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.

Authors:  Latania K Logan; Robert A Weinstein
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

4.  Dynamics of bla KPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity.

Authors:  Ana M Rada; Elsa De La Cadena; Carlos Agudelo; Cesar Capataz; Nataly Orozco; Cristian Pallares; An Q Dinh; Diana Panesso; Rafael Ríos; Lorena Diaz; Adriana Correa; Blake M Hanson; Maria V Villegas; Cesar A Arias; Eliana Restrepo
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

Review 5.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

6.  A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.

Authors:  Ana M Ocampo; Liang Chen; Astrid V Cienfuegos; Gustavo Roncancio; Kalyan D Chavda; Barry N Kreiswirth; J Natalia Jiménez
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

7.  An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the "Perfect Storm".

Authors:  Laura J Rojas; George M Weinstock; Elsa De La Cadena; Lorena Diaz; Rafael Rios; Blake M Hanson; Joseph S Brown; Purva Vats; Daniel S Phillips; Hoan Nguyen; Kristine M Hujer; Adriana Correa; Mark D Adams; Federico Perez; Erica Sodergren; Apurva Narechania; Paul J Planet; Maria V Villegas; Robert A Bonomo; Cesar A Arias
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

8.  A cluster of KPC-2 and VIM-2-producing Klebsiella pneumoniae ST833 isolates from the pediatric service of a Venezuelan Hospital.

Authors:  Aura Falco; Yusibeska Ramos; Esther Franco; Alegría Guzmán; Howard Takiff
Journal:  BMC Infect Dis       Date:  2016-10-22       Impact factor: 3.090

Review 9.  Carbapenem Resistance: A Review.

Authors:  Francis S Codjoe; Eric S Donkor
Journal:  Med Sci (Basel)       Date:  2017-12-21

10.  Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study.

Authors:  Lili Fang; Heping Xu; Xiaoying Ren; Xun Li; Xiaobo Ma; Haijian Zhou; Guolin Hong; Xianming Liang
Journal:  Front Cell Infect Microbiol       Date:  2020-09-14       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.